Enhanced Oral Vaccine Efficacy of Polysaccharide-Coated Calcium Phosphate Nanoparticles
- 17 July 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 5 (29) , 18185-18197
Abstract
Oral administration of vaccines has been limited due to low immune response compared to parenteral administration. Antigen degradation in the acidic gastrointestinal environment (GI), mucus barriers, and inefficient cellular uptake by immune cells are the major challenges for oral vaccine delivery. To solve these issues, the current study investigates calcium phosphate nanoparticles (CaP NPs) coated with polysaccharides as nanocarriers for oral protein antigen delivery. In this design, the CaP NP core had an optimized antigen encapsulation capacity of 90 mg (BSA-FITC)/g (CaP NPs). The polysaccharides chitosan and alginate were coated onto the CaP NPs to protect the antigens against acidic degradation in the GI environment and enhance the immune response in the small intestine. The antigen release profiles showed that alginate-chitosan-coated CaP NPs prevented antigen release in a simulated gastric fluid (pH 1.2), followed by sustained release in simulated intestinal (pH 6.8) and colonic (pH 7.4) fluids. Cellular uptake and macrophage stimulation data revealed that the chitosan coating enhanced antigen uptake by intestine epithelia cells (Caco-2) and macrophages and improved surface expression of costimulatory molecules on macrophages. In vivo test further demonstrated that oral administration of alginate-chitosan-coated [email protected] NPs significantly enhanced the mucosal IgA and serum IgG antibody responses as compared to naked OVA, indicating that the CaP-Chi-Alg nanoparticle can potentially be used as a promising oral vaccine delivery system.Keywords
Funding Information
- Advance Queensland
- Australian Research Council (DP170104643, DP190103486)
- China Scholarship Council
This publication has 45 references indexed in Scilit:
- Exploiting or overcoming the dome trap for enhanced oral immunization and drug deliveryJournal of Controlled Release, 2018
- Current state and challenges in developing oral vaccinesAdvanced Drug Delivery Reviews, 2017
- Recent Developments in nanocarrier-aided Mucosal VaccinationNanomedicine, 2017
- A review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesSaudi Pharmaceutical Journal, 2016
- Peptide nanofiber–CaCO3 composite microparticles as adjuvant-free oral vaccine delivery vehiclesJournal of Materials Chemistry B, 2015
- Stabilization Challenges and Formulation Strategies Associated with Oral Biologic Drug Delivery SystemsAdvanced Drug Delivery Reviews, 2015
- Delivery strategies to enhance oral vaccination against enteric infectionsAdvanced Drug Delivery Reviews, 2015
- Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approachJournal of Controlled Release, 2006
- Is the oral route possible for peptide and protein drug delivery?Drug Discovery Today, 2006
- Vaccination strategies: An overviewVaccine, 2003